Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Debt (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Total Debt for 6 consecutive years, with $51.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt fell 3.47% to $51.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.6 million, a 3.47% decrease, with the full-year FY2025 number at $51.6 million, down 3.47% from a year prior.
  • Total Debt was $51.6 million for Q4 2025 at PROCEPT BioRobotics, roughly flat from $51.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $53.5 million in Q1 2025 to a low of $49.8 million in Q3 2021.
  • A 5-year average of $51.7 million and a median of $51.4 million in 2023 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: rose 4.15% in 2024, then decreased 3.5% in 2025.
  • PROCEPT BioRobotics' Total Debt stood at $50.0 million in 2021, then rose by 2.42% to $51.2 million in 2022, then rose by 3.93% to $53.2 million in 2023, then rose by 0.46% to $53.5 million in 2024, then fell by 3.47% to $51.6 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Total Debt are $51.6 million (Q4 2025), $51.6 million (Q3 2025), and $51.5 million (Q2 2025).